As our designated center of excellence for novel drug delivery systems, Innovaform™ Accelerator is where we help our customers tackle the challenges of oral and inhalable dosage formulation. In this spirit of partnership, we would like to share our latest briefing paper with you. It gives you the key takeaways from the UNGAP network opinion on current intestinal drug absorption research - and where researchers should focus their efforts next.
Latest CHI content
Latest briefing from the Knowledge Center